Thrombogenicity Results Of Cold Sterilized (ß-Propiolactone/Ultraviolet Irradiation) PPSB In Chimpanzees
In vitro tests were demonstrated to be insufficient for the determination of the thrombogenicity of PPSB preparations with peptide substrates or the TGt50 and the NAPTT. Unequivocal determinations of the thrombogenicity of PPSB preparations are possible only up to now in in vivo models. As an alternative to the up to now proposed dog or hemophilia B dog models we have determined the thrombogenicity of cold sterilized PPSB in chimpanzees. PPSB isolated from ß-propiolactone treated and UV irradiated plasma was injected into the chimpanzees at a dose of approximately 100 units/kg body weight. An FDA licensed PPSB preparation served as a control.15 minutes, 1 h, 4 h, and 24 h after the PPSB application the following parameters were determined in the chimpanzee blood: factors II, VII, IX, X, VIII, fibrinogen, AT III, thrombin coagulase, Quick value, APTT and platelet count.Neither the untreated control preparation nor the PPSB from ß-propiolactone treated and UV irradiated plasma showed signs of a thrombogenic effect in this chimpanzee model.